Public Discussion on Considerations for Use of AI in Lay Summary Creation

Hear from representatives of a multi-stakeholder working group that has drafted a good practice considerations document on the responsible use of Artificial Intelligence (AI) in creating plain language trial results summaries (PLS), also known as lay summaries (LS).

The considerations document covers key areas of concern, and recommended practices in the procedural use of AI and governance elements to ensure appropriate human involvement. Technical aspects of AI development and management are not covered.

In this webinar, speakers share the background of this initiative, discuss the purpose and goal of the public comment period, and raise some of the key considerations in the document.

Featured Speakers

Ken Getz

Moderator, CISCRP

Sudipta Chakraborty

Clinical Trial Transparency Lead, Biogen

 

Recommended Posts